Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1
Hao Cai, Yichi Zhang, Jian Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment
Ayana T. Ruffin, Housaiyin Li, Lazar Vujanović, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 3, pp. 173-188
Open Access | Times Cited: 160
Emerging phagocytosis checkpoints in cancer immunotherapy
Yue Liu, Yanjin Wang, Yanrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 154
Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy
Wei Li, Fenglei Wu, Shaolin Zhao, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 67, pp. 49-57
Open Access | Times Cited: 99
ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression
Yu You, Diguang Wen, Lu Zeng, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 13, pp. 5001-5018
Open Access | Times Cited: 75
The promising role of tumor-associated macrophages in the treatment of cancer
Hongbin Wang, Xueying Wang, Xin Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101041-101041
Closed Access | Times Cited: 58
Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials
Wenru Zhang, Mengmeng Wang, Chonghao Ji, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116930-116930
Open Access | Times Cited: 28
Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities
Johannes K. Andersen, Hrvoje Miletić, Jubayer A. Hossain
Cancers (2022) Vol. 14, Iss. 5, pp. 1319-1319
Open Access | Times Cited: 64
Single-Cell Transcriptome Analysis Reveals Inter-Tumor Heterogeneity in Bilateral Papillary Thyroid Carcinoma
Tiantian Wang, Jinyuan Shi, Luchuan Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Testicular macrophages are recruited during a narrow fetal time window and promote organ-specific developmental functions
Xiao‐Wei Gu, Anna Heinrich, Shuyun Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer
Kexun Zhou, Shuo Li, Yi Zhao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
The therapeutic potential of PD-1/PD-L1 pathway on immune-related diseases: Based on the innate and adaptive immune components
Peng Zhang, Yuting Wang, Qianru Miao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115569-115569
Open Access | Times Cited: 24
Macrophage colony-stimulating factor and its role in the tumor microenvironment: novel therapeutic avenues and mechanistic insights
Yi Li, Yihan Gai, Zhuo Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 11
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11
Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence
Jin Zhang, Yue Ma
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116909-116909
Open Access | Times Cited: 11
Glycolysis Induced by METTL14 Is Essential for Macrophage Phagocytosis and Phenotype in Cervical Cancer
Bingyu Wang, Zhonghao Mao, Jinwen Ye, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 4, pp. 723-736
Open Access | Times Cited: 10
Crosstalk between macrophages and natural killer cells in the tumor microenvironment
Jingping Zhou, Shaolong Zhang, Changying Guo
International Immunopharmacology (2021) Vol. 101, pp. 108374-108374
Closed Access | Times Cited: 46
Metabolic Implications of Immune Checkpoint Proteins in Cancer
Elizabeth R. Stirling, Steven M. Bronson, Jessica Mackert, et al.
Cells (2022) Vol. 11, Iss. 1, pp. 179-179
Open Access | Times Cited: 31
Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer
Xia Qiu, Tianjiao Zhao, Ran Luo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 30
Spatially resolved multimarker evaluation of CD274 (PD-L1)/PDCD1 (PD-1) immune checkpoint expression and macrophage polarisation in colorectal cancer
Hanna Elomaa, Maarit Ahtiainen, Sara A. Väyrynen, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 11, pp. 2104-2115
Open Access | Times Cited: 20
Potential Roles and Future Perspectives of Chitinase 3-like 1 in Macrophage Polarization and the Development of Diseases
Hailong Zhao, Mingdong Huang, Longguang Jiang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16149-16149
Open Access | Times Cited: 17
Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors
Hao Li, Shuai Wang, Zhengqiang Yang, et al.
Bioactive Materials (2024) Vol. 36, pp. 376-412
Open Access | Times Cited: 8
Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?
Ruiwen Zhao, Olga Sukocheva, Edmund C. M. Tse, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Therapeutic strategies for gastric cancer targeting immune cells: Future directions
Yan Zhao, Yuansong Bai, Meili Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Immunomodulatory effects of CDK4/6 inhibitors
Shumeng Zhang, Qiaomai Xu, Wenjia Sun, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188912-188912
Closed Access | Times Cited: 16
Dynamic polarization of tumor-associated macrophages and their interaction with intratumoral T cells in an inflamed tumor microenvironment: from mechanistic insights to therapeutic opportunities
Jiashu Han, Luochu Dong, Mengwei Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top